Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Change in Receivables (2020 - 2025)

Rapid Micro Biosystems' Change in Receivables history spans 6 years, with the latest figure at -$618000.0 for Q3 2025.

  • For Q3 2025, Change in Receivables rose 51.38% year-over-year to -$618000.0; the TTM value through Sep 2025 reached $1.7 million, up 1111.98%, while the annual FY2024 figure was $2.0 million, 1119.02% up from the prior year.
  • Change in Receivables for Q3 2025 was -$618000.0 at Rapid Micro Biosystems, down from $1.5 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $3.8 million in Q4 2024 and bottomed at -$3.0 million in Q1 2025.
  • The 5-year median for Change in Receivables is $90000.0 (2024), against an average of $23263.2.
  • The largest annual shift saw Change in Receivables surged 71100.0% in 2022 before it crashed 878.41% in 2023.
  • A 5-year view of Change in Receivables shows it stood at -$1000.0 in 2021, then soared by 71100.0% to $710000.0 in 2022, then soared by 128.87% to $1.6 million in 2023, then surged by 132.55% to $3.8 million in 2024, then tumbled by 116.35% to -$618000.0 in 2025.
  • Per Business Quant, the three most recent readings for RPID's Change in Receivables are -$618000.0 (Q3 2025), $1.5 million (Q2 2025), and -$3.0 million (Q1 2025).